|Day Low/High||5.60 / 5.80|
|52 Wk Low/High||2.95 / 6.23|
This portfolio is designed to produce a blended yield of 6% to 8%.
Company to showcase breakthrough, multi-platform technology for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers at booth #T1
Latest digital breast 3D tomosynthesis solution builds on deep learning technology to improve radiologist workflow and significantly reduce reading time
First to market with innovative digital breast 3D tomosynthesis cancer detection and workflow solution, built on deep learning technology that improves efficiency and reduces reading time for radiologists
Company to showcase breakthrough one-day breast cancer treatment technology and host in-booth clinician expert at Physicians' Education Resource® 34th Annual Miami Breast Cancer Conference
Company to highlight breakthrough Xoft System offering excellent clinical results and host in-booth Lunch and Learn sessions featuring clinical experts to discuss strategies and outcomes in patient care
Results show low morbidity, excellent-to-good cosmetic results, and low-grade adverse events for patients with early-stage breast cancer
Company highlighting latest in deep learning technology used to detect cancer earlier and improve workflow
Multi-platform Xoft electronic brachytherapy system brings versatility and mobility to clinicians
Grade "A" assigned to colorectal cancer screening exams by United States Preventive Services Task Force
Momentum reflects response to state mandated breast density notifications and healthcare provider confidence in iCAD's radiology workflow solution platform
iCAD, Inc., (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, today announced that its mammography Computer...
Company highlights new SMART solution designed to enhance workflow efficiency, flexibility, safety and security of the Xoft System